Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Fabry disease: a new approach for the screening of females in high-risk groups.
[fabry disease]
Fabry
disease
(
FD
)
is
a
rare
X-
linked
inborn
error
of
metabolism
caused
by
deficient
activity
of
lysosomal
α-galactosidase
A
(
α-
GAL
)
.
Due
to
random
X
inactivation
,
α-
GAL
activity
in
heterozygous
females
ranges
from
very
low
to
overlapping
normal
values
.
Determining
this
specific
range
and
altering
assays
cutoffs
could
become
a
valuable
tool
for
minimizing
the
need
in
DNA
sequencing
for
screening
of
all
potential
carriers
.
Therefore
,
the
aim
of
this
study
was
to
establish
the
range
of
enzyme
in
dried
blood
spots
(
DBS
)
,
plasma
and
leukocytes
that
suggests
carrier
status
for
FD
.
α-
GAL
gene
was
sequenced
in
453
women
with
clinical
suspicion
and
/
or
positive
family
history
of
FD
.
This
data
was
compared
to
the
α-
GAL
activity
measured
in
DBS
(
dried
blood
spots
)
and
/
or
plasma
and
/
or
leukocytes
.
About
12
%
of
the
samples
had
pathogenic
mutations
(
c
.
30
_
32
delG
,
c
.
718
_
719
delAA
,
p
.
R
118
C
,
p
.
S
126
G
,
p
.
Y
152
X
,
p
.
A
156
D
,
p
.
C
2
02
Y
,
p
.
N
215
S
,
p
.
P
259
R
,
p
.
D
264
Y
,
p
.
V
269
M
,
p
.
R
342
Q
and
p
.
R
356
W
)
.
When
compared
to
genotype
,
DBS
was
the
least
reliable
biochemical
test
for
screening
,
with
very
low
specificity
.
Plasma
and
leukocyte
activities
presented
high
AUC
in
ROC
curve
analysis
,
both
over
84
%
.
When
cutoffs
were
altered
to
identify
all
carriers
,
leukocyte
specificity
was
higher
than
that
of
plasma
(
35
.
2
%
and
27
.
6
%
,
respectively
)
.
Moderated
correlation
and
agreement
coefficients
were
found
between
them
,
which
reinforces
the
need
for
using
both
data
combined
.
A
combined
approach
involving
plasma
and
leukocyte
α-
GAL
activities
,
with
distinct
cutoffs
for
men
and
women
,
could
represent
a
more
accurate
,
faster
and
less
expensive
tool
to
screen
women
for
FD
in
high
-risk
groups
in
middle
-
and
low
-income
countries
.
Diseases
Validation
Diseases presenting
"altering assays cutoffs could become a valuable tool for minimizing the need in dna sequencing for screening of all potential carriers"
symptom
fabry disease
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom